高级检索
当前位置: 首页 > 详情页

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
参与国家:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究单位: [1]Janssen Research & Development, LLC [2]Bristol Myers Squibb Company (BMS) [3]University Multiprofile Hospital for Active Treatment - Tsaritsa Yoanna - ISUL, EAD,Sofia,Bulgaria,1527 [4]UMHATEM N I Pirogov,Sofia,Bulgaria,1606 [5]University of Calgary,Calgary,Alberta,Canada,T2N 4Z6 [6]University of Alberta Hospital,Edmonton,Alberta,Canada,T6G 2B7 [7]Royal Columbian Hospital,New Westminster,British Columbia,Canada,V3L 3W4 [8]Vancouver General Hospital,Vancouver,British Columbia,Canada,V5Z 1M9 [9]Clinica Alemana de Santiago S.A.,Santiago,Chile [10]Hospital Clinico Vina del Mar,Vina del Mar,Chile,2520612 [11]The People's Hospital of Anyang City,Anyang,China,455002 [12]Baoji Central Hospital,Baoji,China,721008 [13]Xuanwu Hospital ,Capital Medical University,Beijing,China,100053 [14]Beijing Tiantan Hospital, Capital Medical University,Beijing,China,100070 [15]Peking University Third Hospital,Beijing,China,100191 [16]Jilin Province Peoples Hospital,Changchun,China,130021 [17]The First Hospital of Jilin University,Changchun,China,130021 [18]Hunan Province People's Hospital The First Affiliated Hospital of Hunan Normal University,Changsha,China,410002 [19]The second Xiangya Hospital of Central South University,Changsha,China,410011 [20]Changsha Central Hospital,Changsha,China,410018 [21]Chengdu Second People's Hospital,Chengdu,China,610021 [22]The First Affiliated Hospital of Chengdu Medical College,Chengdu,China,610500 [23]Chenzhou No.1 People's Hospital,Chenzhou,China,432000 [24]PLA Army Characteristic Medical Center,Chongqing,China,400042 [25]Affiliated Zhongshan Hospital of Dalian University,Dalian,China,116001 [26]Dalian Municipal Central Hospital,Dalian,China,116021 [27]Dazhou Central Hospital,Dazhou,China,635000 [28]Dongguan People s Hospital,Dongguan,China,523059 [29]Jiangxi Ganzhou Peoples Hospital,Ganzhou,China,341000 [30]Guangdong Provincial People's Hospital,Guangzhou,China,510080 [31]Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University,Guangzhou,China,510120 [32]Guangzhou First Municipal People's Hospital,Guangzhou,China,510180 [33]Guangdong Second Provincial General Hospital,Guangzhou,China,510317 [34]The Affiliated Hospital of Hangzhou Normal University,Hangzhou,China,310000 [35]Zhejiang Provincial People's Hospital,Hangzhou,China,310000 [36]Zhejiang Hospital,Hangzhou,China,310007 [37]Inner Mongolia People's Hospital,Huhehaote,China,010017 [38]Qilu Hospital of Shandong University,Jinan,China,250012 [39]Shandong First medical university,Jinan,China,250014 [40]Jingdezhen No.1 People's Hospital,Jingdezhen,China,333000 [41]The No.2 Hospital affiliated to Guizhou Medical college,Kaili,China,556000 [42]First Peoples Hospital of Yunnan Province,Kunming,China [43]The First Hospital of Lanzhou University,Lanzhou,China,730000 [44]The Second People's Hospital of Lianyungang,Lianyungang,China,222006 [45]Liaocheng People s Hospital,Liaocheng,China,252000

研究目的:
The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

资源点击量:82478 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号